Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 0.918 Q2 | 202 | 332 | 835 | 40345 | 2886 | 780 | 3.22 | 121.52 | |
2 | Current Drug Targets | journal | 0.825 Q2 | 119 | 171 | 558 | 16711 | 1326 | 491 | 2.22 | 97.73 | |
3 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.528 Q3 | 108 | 218 | 518 | 13123 | 1043 | 487 | 1.91 | 60.20 | |
4 | Letters in Drug Design and Discovery | journal | 0.207 Q4 | 37 | 162 | 385 | 5795 | 335 | 381 | 0.93 | 35.77 | |
5 | Mini-Reviews in Medicinal Chemistry | journal | 0.609 | 107 | 124 | 419 | 9892 | 1022 | 373 | 2.49 | 79.77 | |
6 | Letters in Organic Chemistry | journal | 0.205 Q4 | 33 | 155 | 333 | 5495 | 240 | 329 | 0.73 | 35.45 | |
7 | Current Nanoscience | journal | 0.336 Q3 | 52 | 65 | 285 | 2563 | 407 | 259 | 1.51 | 39.43 | |
8 | Current Protein and Peptide Science | journal | 0.599 Q3 | 96 | 116 | 296 | 11924 | 552 | 253 | 1.52 | 102.79 | |
9 | Current Organic Synthesis | journal | 0.377 Q3 | 55 | 83 | 239 | 6372 | 379 | 224 | 1.70 | 76.77 | |
10 | Current Cancer Drug Targets | journal | 0.875 Q3 | 103 | 87 | 227 | 8117 | 521 | 202 | 2.15 | 93.30 | |
11 | Current Bioinformatics | journal | 0.234 Q4 | 38 | 68 | 213 | 2843 | 156 | 194 | 0.96 | 41.81 | |
12 | Current Pharmaceutical Analysis | journal | 0.218 Q4 | 27 | 82 | 177 | 2329 | 119 | 168 | 0.70 | 28.40 | |
13 | Current Diabetes Reviews | journal | 0.733 Q3 | 68 | 59 | 156 | 4300 | 350 | 139 | 2.16 | 72.88 | |
14 | Current Genomics | journal | 0.765 Q3 | 77 | 65 | 153 | 6155 | 367 | 132 | 2.06 | 94.69 | |
15 | Current Gene Therapy | journal | 1.008 Q2 | 80 | 41 | 139 | 3484 | 338 | 128 | 2.16 | 84.98 | |
16 | Open Biotechnology Journal | journal | 0.162 Q4 | 18 | 26 | 111 | 1557 | 66 | 107 | 0.71 | 59.88 | |
17 | Current Aging Science | journal | 0.476 Q4 | 42 | 32 | 109 | 1679 | 152 | 98 | 1.35 | 52.47 | |
18 | Current Proteomics | journal | 0.212 Q4 | 27 | 47 | 106 | 2025 | 69 | 98 | 0.82 | 43.09 | |
19 | Current Computer-Aided Drug Design | journal | 0.265 Q4 | 32 | 38 | 113 | 1534 | 109 | 95 | 1.03 | 40.37 | |
20 | Current Molecular Pharmacology | journal | 0.774 Q3 | 49 | 34 | 99 | 2857 | 178 | 83 | 1.22 | 84.03 | |
21 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.529 Q3 | 52 | 33 | 88 | 3586 | 192 | 82 | 2.10 | 108.67 | |
22 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.351 Q4 | 39 | 22 | 92 | 1459 | 96 | 77 | 0.97 | 66.32 | |
23 | Journal of Biology and Today's World (discontinued) | journal | 0.168 Q4 | 8 | 0 | 76 | 0 | 38 | 75 | 0.50 | 0.00 | |
24 | Infectious Disorders - Drug Targets | journal | 0.351 Q4 | 61 | 34 | 83 | 1174 | 85 | 74 | 0.87 | 34.53 | |
25 | Recent Patents on Biotechnology | journal | 0.239 Q3 | 42 | 28 | 74 | 1801 | 60 | 66 | 0.74 | 64.32 | |
26 | Drug Metabolism Letters | journal | 0.312 Q3 | 31 | 20 | 74 | 622 | 64 | 65 | 0.88 | 31.10 | |
27 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.293 Q4 | 45 | 31 | 66 | 1834 | 76 | 61 | 1.00 | 59.16 | |
28 | Current Enzyme Inhibition | journal | 0.153 Q4 | 19 | 20 | 61 | 698 | 26 | 54 | 0.34 | 34.90 | |
29 | International Journal of Engineering and Technology(UAE) (discontinued) | journal | 0.113 Q4 | 37 | 5548 | 53 | 111678 | 37 | 53 | 0.70 | 20.13 | |
30 | Current Cancer Therapy Reviews | journal | 0.140 Q4 | 17 | 15 | 63 | 860 | 12 | 52 | 0.22 | 57.33 | |
31 | Current Pharmacogenomics and Personalized Medicine | journal | 0.112 Q4 | 20 | 21 | 56 | 1270 | 6 | 50 | 0.16 | 60.48 | |
32 | Current Signal Transduction Therapy | journal | 0.138 Q4 | 22 | 20 | 54 | 961 | 21 | 49 | 0.66 | 48.05 | |
33 | Current Chemical Biology | journal | 0.159 Q4 | 26 | 18 | 50 | 1131 | 48 | 47 | 1.06 | 62.83 | |
34 | Open Medicinal Chemistry Journal | journal | 0.237 Q4 | 23 | 12 | 22 | 455 | 24 | 22 | 1.26 | 37.92 | |
35 | Current Angiogenesis | journal | 0.104 Q4 | 6 | 0 | 12 | 0 | 1 | 11 | 0.00 | 0.00 | |
36 | Current Metabolomics | journal | 0.288 Q3 | 4 | 0 | 9 | 0 | 10 | 8 | 0.83 | 0.00 | |
37 | Open Biomarkers Journal | journal | 0.124 Q4 | 7 | 6 | 1 | 250 | 0 | 1 | 0.00 | 41.67 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®